Clinical Trials Browser

Phase 3 × apixaban × 90 days × Clear all

NCT07493304 2026-03-25

ROXI-CAT-II

Phase 3 Not yet recruiting

Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT05171049 2026-02-23

ASTER

Phase 3 Terminated

Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT07005024 2026-02-05

DOAC

Phase 3 Recruiting

Classical hematology

Neoplasms, Venous Thromboembolism